Sagimet Biosciences Inc. SEC filings SGMT
Sagimet Biosciences Inc. has 262 filings in SEC EDGAR's recent list, going back to May 8, 2007. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Sep 30, 2026 |
| 424B5 | Prospectus supplement | Oct 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 424B3 | Prospectus | Sep 30, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 28, 2026 | Apr 27, 2026 |
| 424B5 | Prospectus supplement | Apr 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2026 | Mar 11, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 22, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 14, 2025 | Aug 14, 2025 |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 9, 2025 |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| S-8 | Employee stock plan registration | Mar 12, 2025 | — |
| S-8 | Employee stock plan registration | Mar 12, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Mar 12, 2025 | Mar 12, 2025 |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Aug 26, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 16, 2024 | Aug 15, 2024 |
| S-3 | Shelf registration | Aug 15, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jul 2, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 13, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change
|
May 6, 2024 | May 3, 2024 |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | Jun 5, 2024 |
| S-8 | Employee stock plan registration | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 25, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 25, 2024 |
| 424B4 | Prospectus | Jan 29, 2024 | — |
| EFFECT | Filing | Jan 25, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jan 24, 2024 | Jan 23, 2024 |
| S-1/A | Amended registration statement | Jan 24, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| S-1 | Registration statement | Jan 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 22, 2024 | Jan 22, 2024 |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| DRS | Filing | Jan 10, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 29, 2023 | Dec 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2023 | Nov 17, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 21, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 21, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 18, 2023 | Jul 18, 2023 |
| S-8 | Employee stock plan registration | Jul 17, 2023 | — |
| 424B4 | Prospectus | Jul 17, 2023 | — |
| SEC STAFF LETTER | Filing | Jul 14, 2023 | — |
| EFFECT | Filing | Jul 13, 2023 | — |
| S-1MEF | Filing | Jul 13, 2023 | — |
| CERT | Filing | Jul 13, 2023 | — |
| 8-A12B | Filing | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 10, 2023 | — |
| S-1/A | Amended registration statement | Jul 10, 2023 | — |
| SEC STAFF LETTER | Filing | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| S-1/A | Amended registration statement | Jul 3, 2023 | — |
| S-1 | Registration statement | Jun 23, 2023 | — |
| SEC STAFF LETTER | Filing | May 15, 2023 | — |
| DRS/A | Filing | May 11, 2023 | — |
| DRSLTR | Filing | May 10, 2023 | — |
| DRSLTR | Filing | Apr 25, 2023 | — |
| DRS/A | Filing | Apr 25, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2023 | — |
| DRS | Filing | Mar 24, 2023 | — |
| RW | Filing | Mar 21, 2022 | — |
| S-1/A | Amended registration statement | May 10, 2021 | — |
| S-1 | Registration statement | Apr 16, 2021 | — |
| DRS | Filing | Mar 11, 2021 | — |
| D | Filing | Jan 5, 2021 | — |
| D | Filing | Feb 25, 2019 | — |
| D | Filing | Jul 5, 2016 | — |
| D | Filing | Mar 17, 2015 | — |
| D | Filing | Jun 27, 2013 | — |
| D/A | Filing | Dec 20, 2012 | — |
| D | Filing | Dec 12, 2011 | — |
| D | Filing | Jul 22, 2009 | — |
| REGDEX | Auto-generated paper document | May 8, 2007 | — |
Showing 133 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SGMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1400118
- Former names
- 3-V Biosciences, Inc. (until Feb 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.